Pain News and Research

Latest Pain News and Research

Vemurafenib nearly doubles survival for patients with metastatic melanoma

Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.

23 Feb 2012

Accelitech embarks on a proton cancer therapy project

Accelitech LLC, the leader in the development and full-cycle management of technology-driven cancer treatment programs, is pleased to announce its inaugural proton therapy project. The treatment center project, now under development, is the latest in Accelitech's ongoing effort to bring leading treatment technologies to more patients through joint-venture partnerships with physicians and hospitals.

23 Feb 2012

Chemists build light-controlled neural inhibitor

The notion of a pain switch is an alluring idea, but is it realistic? Well, chemists at LMU Munich, in collaboration with colleagues in Berkeley and Bordeaux, have now shown in laboratory experiments that it is possible to inhibit the activity of pain-sensitive neurons using an agent that acts as a photosensitive switch. For the LMU researchers, the method primarily represents a valuable tool for probing the neurobiology of pain.

23 Feb 2012

Osseon's new vertebral augmentation device receives European CE Mark approval

Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.

22 Feb 2012

Gluten-free diet more of a fad than absolute necessity for many

Many people claim that gluten sensitivity is on the rise and consequently gluten-free products are more popular than ever. A study explores whether shunning gluten is really necessary and finds that in most cases it is not.

22 Feb 2012

Silent & atypical heart attacks more dangerous & fatal in young women

It is known that chest pain or discomfort is the most common heart attack symptom. In addition, fatigue, nausea, shortness of breath and pain or numbness in the jaw, arms or back can also signal a blocked artery cutting off vital oxygen and nutrients from the heart.

22 Feb 2012

Bid to raise awareness of risks and symptoms of ovarian cancer: The 2012 Teal Ribbon Day

Ovarian Cancer Australia has found less than one per cent of women know they're at risk if there's a family history of ovarian cancer on their father's side. And only 42 per cent know a history on their mother's side puts them at increased risk.

22 Feb 2012

AAN announces recipients of 2012 scientific research awards

Nearly two dozen scientific research awards are being bestowed on researchers around the world this year by the American Academy of Neurology, the world's largest association of neurologists. The awards will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21-28, 2012, at the New Orleans Ernest N. Morial Convention Center.

22 Feb 2012

BioLineRx BL-7010 may reduce gluten toxicity in patients with celiac disease

BioLineRx, a biopharmaceutical development company, announced the publication of pre-clinical results demonstrating that BL-7010, an orally available treatment for celiac disease, reduces gluten toxicity (the negative effect of gluten on the patient's body).

22 Feb 2012

New chemical compound to treat brain damage from stroke

Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke. The compound binds 1,000 times more effectively to the target protein in the brain than the potential drug currently being tested on stroke victims.

22 Feb 2012

Perioperative IT sees significant growth in Anesthesia Information Management Systems

Perioperative IT is seeing significant growth, particularly in Anesthesia Information Management Systems (AIMS) and analytics solutions, according to Atlanta-based Surgical Information Systems ("SIS"). In a recent survey of healthcare decision makers, 84% of those surveyed consider IT solutions as a strategic driver of success in the OR. The survey of 292 healthcare decision makers was sponsored by SIS.

21 Feb 2012

Drug 'addicted' newborn the latest hysteria driven absurdity

The Florida Society of Pain Management Providers (www.Flspmp.org) feels it is vital to set the factual record straight in light of the mass deception used to foment a hysteria driven war on pain medications that now is threatening the health and welfare of Florida's chronic pain patients.

21 Feb 2012

Mothers who suffer migraine headaches more likely to have babies with colic

A study of mothers and their young babies by neurologists at the University of California, San Francisco (UCSF) has shown that mothers who suffer migraine headaches are more than twice as likely to have babies with colic than mothers without a history of migraines.

21 Feb 2012

ZirMed launches VeraFund Manager for healthcare providers

ZirMed, a preeminent provider of revenue cycle and information solutions for healthcare, today announced the launch of VeraFund Manager for healthcare providers. Available exclusively from ZirMed and utilizing advanced payment and remittance processing support from BNY Mellon, the service delivers an end-to-end automated patient/payer solution for healthcare providers.

20 Feb 2012

Belkin, Peerless partner to provide PeerCare EMR Hybrid Cart

Belkin today announced a strategic partnership with Peerless Industries, Inc., a designer, manufacturer and distributor of audio-visual solutions. The partnership will initially yield the PeerCare Electronic Medical Records (EMR) Hybrid Cart, fitted with a unique modular battery power system.

20 Feb 2012

Massive infant Tylenol recall

Johnson & Johnson has announced the recall of its entire U.S. supply of infants' Tylenol—about 574,000 bottles—due to a design flaw. The flaw involved bottles of grape-flavoured infants' Tylenol, which had only just returned to shelves in November announced J&J last Friday.

20 Feb 2012

EC approves Plexxikon's Zelboraf to treat BRAF mutation-positive MM

Plexxikon Inc., a member of Daiichi Sankyo Group, today announced that the European Commission has approved Zelboraf (vemurafenib) for the monotherapy treatment of adult patients with BRAFV600 mutation-positive unresectable or metastatic melanoma.

20 Feb 2012

Modified imatinib cancer drug prevents morphine tolerance in rats

By reformulating the common cancer drug imatinib (Gleevec), researchers have eliminated morphine tolerance in rats - an important step toward improving the effectiveness of chronic pain management in patients, according to researchers at The University of Texas MD Anderson Cancer Center.

20 Feb 2012

Researchers discover class of proteins that detect 'painful touch'

In two landmark papers in the journal Nature this week, scientists at The Scripps Research Institute report that they have identified a class of proteins that detect "painful touch."

19 Feb 2012

Remote controlled microchip successfully delivers drug in early clinical trial

Researchers have developed a new microchip implant device that can deliver bone-building drugs to seven osteoporosis patients. The microchips worked inside patients as drug-delivering pacemakers, following a prescription plan sent by radio signal.

18 Feb 2012